www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

USEUROPEAFRICAASIA 中文雙語Fran?ais
Home / Advertorial

A network approach to innovation

By Zhuan Ti | China Daily | Updated: 2015-06-24 07:42

Johnson & Johnson is fostering a collaborative approach to tap into the best science and technology

In a interview with China Daily, Paul Stoffels, chief scientific officer and chairman of pharmaceuticals of Johnson & Johnson, talked about the company's strategy on innovation, globally and domestically. The Janssen Pharmaceutical Companies of Johnson & Johnson are named after Dr Paul Janssen, a leading Belgian researcher, pharmacologist and general practitioner.

Johnson & Johnson has made a major commitment to collaboration to advance innovation. How does the approach work for the company locally and globally?

Our vision is to positively impact human health through innovation. We are committed to fostering a networked approach to innovation because it enables us to tap into the best science and technology, no matter where it is, to solve the greatest unmet needs of our time.

Our approach is to source the best external innovation and invest in highly differentiated early-stage innovations that will turn into products that extend and improve lives everywhere. We also seek to nurture the global innovation ecosystem to ensure its continued vibrancy.

What is the J&J approach to networked innovation?

Our innovation centers are the cornerstone of our approach to networked innovation. They are located in key innovation hotspots around the world including Boston, California, London and the Asia-Pacific.

The innovation centers were created to meet the needs of entrepreneurs and scientists developing medical devices and diagnostic technologies, consumer healthcare products and pharmaceuticals. Through them, there is robust exchange of and support for new ideas, which is critical to advancing important products.

How are the J&J innovation centers structured?

Each of our innovation centers houses a fully integrated team of scientific and business experts and flexible deal-making capabilities to meet the needs of any company.

We invest at very early stages of innovation all the way up to and including proof-of-concept objectives, such as early-stage research funding, seed funding, equity investments, licensing and collaborations.

Also, through our innovation centers, our scientists, technology experts, clinical researchers and other professionals work with our collaborators to provide a broad range of R&D support across our therapeutic areas of focus from discovery and early development through clinical trial design and regulatory strategy.

What are your plans for growth in the Asia-Pacific region?

Ongoing industry-wide and government investment in the Asia-Pacific region, coupled with support from companies like Johnson & Johnson, will attract and nurture the best in science and technology from the region. Together we can help advance innovation, address unmet health needs and create unparalleled new value that helps to grow the economy.

We recently launched our Asia-Pacific Innovation Center in Shanghai and have done a number of deals throughout the region, including in China.

We entered into a broad collaboration with Wuxi App Tec to source and advance transformational new healthcare products by providing resources and capabilities, such as talent, facilities and funding, to set up asset-centric development companies.

Product candidates will be sourced globally and developed in China for the global market. We also have a number of R&D collaborations with academic organizations, including China Pharmaceutical University, Peking University and Zhejiang University. These collaborations focus on advancing new science in areas of focus for J&J such as central nervous system, oncology and consumer healthcare.

zhuanti@chinadaily.com.cn

A network approach to innovation

(China Daily 06/24/2015 page6)

Today's Top News

Editor's picks

Most Viewed

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 国产精品久久久香蕉 | 日韩一区二区不卡中文字幕 | 国产精品一区伦免视频播放 | 成人午夜视频免费观看 | 日韩精品久久久毛片一区二区 | 国产精品久久久久久福利漫画 | 成人欧美在线观看 | 在线国产一区二区 | 国产欧美日韩另类 | 欧美a级毛片免费播敢 | 国产成人精品日本亚洲麻豆 | 国产三级小视频 | 日韩在线看片中文字幕不卡 | 国产精在线 | 在线视频亚洲 | 怡红院最新免费全部视频 | 在线精品欧美日韩 | 国产91一区二这在线播放 | 久草在线在线观看 | 精品国产欧美一区二区 | 97久久国语露脸精品对白 | 免费ab | 国产香蕉尹人综合在线观 | 亚洲性久久 | 国产a毛片 | 男女视频在线看 | 国产高清视频在线观看 | 亚州免费一级毛片 | 亚洲美女在线观看亚洲美女 | 一区二区三区四区视频在线 | avtom影院入口永久在线 | 欧美一级特黄aa大片视频 | 在线观看国产区 | 欧美特黄一级视频 | 国产日产欧美精品一区二区三区 | 国产成人精品免费久久久久 | 成人在线视频一区 | 欧美成人手机在线 | 欧美视频一区二区三区在线观看 | 美美女下面被cao爽 美女131爽爽爽做爰中文视频 | 欧美在线一级精品 |